The Precision Medicine Initiative (PMI) and the Translational Precision Medicine Complex (TPMC) are a top-priority research investment for the UM System and both projects seek to enable researchers and clinicians to collaborate using the most advanced technologies and data analysis tools. Together, these critical initiatives will support “bench-to-bedside” approach; accelerate the development of novel diagnostic tools and treatments; and allow for fast tracking of the application of proven medical strategies to clinical settings.
Upcoming Progress Report Events
There are no upcoming progress reports. Please check back, as new events will be posted as they are planned.
Past Progress Report Events
Bringing the Vision to Life (February 6, 2019)
|Welcome and Introductions||Mark McIntosh, UM System Vice President, Research and Economic Development and MU Vice Chancellor of Research, Graduates Studies and Economic Development|
|Building Design and Components||Burns & McDonnell, Chief Architects of the TPMC|
|Overview (Planning Process, TPMC Operational Plans and Expectations, Innovation Space and Corporate Relationships)||Elizabeth Loboa, Dean of the MU College of Engineering and MU Vice Chancellor for Strategic Partnerships|
|Research Working Group Reports|
|Vascular Working Group||Kerry McDonald, Interim Chair, Medical Pharmacology and Physiology|
|Cancer Working Group||Jeffrey Bryan, Professor of Oncology, Department of Veterinary Medicine|
|Neurological Working Group||David Schulz, Professor of Biological Sciences|
|Marketing Report||Kamrhan Farwell, UM System Chief Marketing and Communications Officer|
|Finance Report||Ryan Rapp, UM System Vice President for Finance and Chief Financial Officer and Rhonda Gibler, MU Vice Chancellor of Finance|
|Government Relations Report||Dusty Schnieders, UM System Director of Government Relations|
|Philanthropy Update||Tom Hiles, MU Vice Chancellor for University Advancement|